On January 22, 2026, the U.S. Bureau of Economic Analysis (BEA) put out its second estimate for the third quarter of 2025, showing real GDP grew by 4.4%. This is a jump from the first estimate of 3.8% and beats what the market expected. The economy showed strength in many areas, with good increases in consumer spending, exports, government spending, and business investment. Imports went down, which also helped push the numbers up, suggesting strong demand at home and better trade during July–September.
The 4.4% growth rate is faster than the second quarter of 2025, showing the U.S. economy can keep going strong even with past problems. This update is important because a government shutdown held up earlier reports. This second estimate now takes the place of what would have been the final numbers. The main things that helped growth were more consumer spending, better exports, more government spending, and higher business investment. This all points to a healthy economy as we went into late 2025.
Even though there will be a final third estimate soon, the current 4.4% number is a strong sign that the U.S. economy is doing well at the start of 2026. This surprise increase makes investors and leaders more confident and points to ongoing consumer and business activity, even with problems around the world. This new data supports the idea that the economy is still expanding and could change what people expect the Federal Reserve to do in the future.


Federal Reserve Balance Sheet Reduction: Brookings Research Outlines Possible Path Forward
Gold is meant to be a ‘safe haven’ in uncertain times. Why is it crashing amid a war?
Trump Tariffs Show Minimal Economic Impact but Boost Federal Revenue, Study Finds
Time to buy local: war fuel price shocks reveal the folly of a long food supply chain
God on their side: how the US, Israel and Iran are all using religion to garner support
Makemation: a Nollywood movie that shows AI in action in Africa
Will a new border deal with the US open a backdoor into Kiwis’ personal data?
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 



